154 related articles for article (PubMed ID: 8482560)
21. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
22. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
24. Gynecologic Oncology Group experience with ifosfamide.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
[TBL] [Abstract][Full Text] [Related]
25. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.
Crotzer DR; Wolf JK; Gano JB; Gershenson DM; Levenback C
Gynecol Oncol; 2007 May; 105(2):399-403. PubMed ID: 17292457
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
[TBL] [Abstract][Full Text] [Related]
27. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Muderspach LI; Blessing JA; Levenback C; Moore JL
Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
[TBL] [Abstract][Full Text] [Related]
28. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
31. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).
Sutton GP; Blessing JA; Rosenshein N; Photopulos G; DiSaia PJ
Am J Obstet Gynecol; 1989 Aug; 161(2):309-12. PubMed ID: 2548382
[TBL] [Abstract][Full Text] [Related]
33. Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892).
Dreicer R; Propert KJ; Roth BJ; Einhorn LH; Loehrer PJ
Cancer; 1997 Jan; 79(1):110-4. PubMed ID: 8988734
[TBL] [Abstract][Full Text] [Related]
34. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
35. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
36. Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease.
Hannigan EV; Dinh TV; Doherty MG
Gynecol Oncol; 1991 Nov; 43(2):123-8. PubMed ID: 1743553
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
Thigpen T; Blessing JA; Gallup DG; Maiman M; Soper JT
Gynecol Oncol; 1995 Jun; 57(3):376-9. PubMed ID: 7774841
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
Olver I; Keefe D; Myers M; Caruso D
Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
[TBL] [Abstract][Full Text] [Related]
40. Gynecologic Oncology Group studies with ifosfamide.
Sutton GP; Blessing JA; Manetta A; Homesley H; McGuire W
Semin Oncol; 1992 Dec; 19(6 Suppl 12):31-4. PubMed ID: 1485172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
